10-117134130-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001112704.2(VAX1):c.883A>G(p.Met295Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000495 in 1,535,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001112704.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VAX1 | NM_001112704.2 | c.883A>G | p.Met295Val | missense_variant | 3/3 | ENST00000369206.6 | NP_001106175.1 | |
VAX1 | NM_199131.3 | c.430-1653A>G | intron_variant | NP_954582.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VAX1 | ENST00000369206.6 | c.883A>G | p.Met295Val | missense_variant | 3/3 | 5 | NM_001112704.2 | ENSP00000358207.4 | ||
VAX1 | ENST00000277905.6 | c.430-1653A>G | intron_variant | 1 | ENSP00000277905.2 |
Frequencies
GnomAD3 genomes AF: 0.000290 AC: 44AN: 151954Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000785 AC: 11AN: 140080Hom.: 0 AF XY: 0.0000803 AC XY: 6AN XY: 74682
GnomAD4 exome AF: 0.0000231 AC: 32AN: 1383794Hom.: 0 Cov.: 32 AF XY: 0.0000147 AC XY: 10AN XY: 682290
GnomAD4 genome AF: 0.000290 AC: 44AN: 151954Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74208
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.883A>G (p.M295V) alteration is located in exon 3 (coding exon 3) of the VAX1 gene. This alteration results from a A to G substitution at nucleotide position 883, causing the methionine (M) at amino acid position 295 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 06, 2015 | - - |
Microphthalmia, syndromic 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 12, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 196313). This variant has not been reported in the literature in individuals affected with VAX1-related conditions. This variant is present in population databases (rs794727489, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 295 of the VAX1 protein (p.Met295Val). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at